Merck & Co., Inc. is seeking an EU HTA Dossier Lead to oversee the end-to-end EU HTA delivery for oncology products, ensuring alignment between EU-level assessments and national access, pricing, and reimbursement strategies. The ideal candidate should possess significant experience in Market Access and Health Technology Assessment, with strong leadership and cross-functional collaboration skills
Job Summary
The role sits at the intersection of EMA regulatory, EU and national HTA, leading the EU HTA part and supporting the translation of EU-level assessments into meaningful implications for country Access, Pricing and Reimbursement strategies.
Own end-to-end EU HTA planning and execution at asset level (oncology focus through 2028), from early PICO anticipation through JCA submission and downstream impact assessment.
Contribute to EU HTA readiness, including development of standards, processes and new ways of working.
Matching Summary
Match Score: 85
Merck & Co., Inc. is seeking an EU HTA Dossier Lead to oversee the end-to-end EU HTA delivery for oncology products, ensuring alignment between EU-level assessments and national access, pricing, and reimbursement strategies. The ideal candidate should possess significant experience in Market Access and Health Technology Assessment, with strong leadership and cross-functional collaboration skills.
Skills & Requirements
Must-have
EU HTA Regulation expertise
End-to-end HTA dossier leadership
Cross-functional team leadership
Market Access & HTA strategy
Joint Scientific Consultations (JSCs)
Nice-to-have
Influential collaborator without authority
Strategic counsel to senior leaders
Innovative, entrepreneurial mindset
High cultural awareness
Key Requirements
Minimum 5 years of Market Access / HTA experience
Post-graduate degree in Public Health, Health Economics, Health Policy
Demonstrated leadership of end-to-end national HTA dossier development